Given the recent guidance released by the CDC and FDA recommending that the U.S. pause the use of Johnson & Johnson's Covid-19 vaccine, Grant Regional Health Center will pause our administration of the J&J vaccine at this time.
If patients have questions specific to their care, we encourage them to please contact their primary care provider. If patients feel they have urgent questions or concerns, they can be seen in our ER/Walk-In Care.
- FDA is reviewing data involving six reported U.S. cases (of 6.8 million administered doses of the Johnson & Johnson COVID-19 vaccine) of a rare and severe type of blood clot in individuals after receiving Johnson and Johnson vaccine.
- Out of an abundance of caution Grant Regional will pause administration of the J&J vaccine.
- Patients should to contact their health care provider if experiencing:
- Severe headache, abdominal pain, leg pain, or shortness of breath within three weeks of vaccination
- The six adverse events appear to be extremely rare and the federal government is pausing out of an abundance of caution for the J&J vaccine. Wisconsin has not reported any cases at this time.
- We encourage patients to use V-safe app for monitoring of response and potential side effects.
- Moderna and Pfizer vaccines continue be a safe and effective option and will continue to be offered.
- GRHC is in the process of contacting patients who received the J&J at our hospital to make them aware, and answer questions.
- This pause validates the important safety measures in place and that monitoring the COVID-19 vaccine is working as it should.
We will keep you updated as we learn more information.